UHS is now AGILITI: The people you know and the services you trust remain the same.

RES is Now Agiliti
Our name has changed, but our commitment to quality service remains the same.



Agiliti , Inc. Announces 2015 First Quarter Results

Posted: May 13, 2015


Agiliti , Inc. (“UHS”), a leading provider of health
care technology management and service solutions, today announced
financial results for the quarter ended March 31, 2015.

Total revenues were $113.5 million for the first quarter of 2015,
representing a $0.2 million or 0.1% increase from total revenues of
$113.3 million for the same period of 2014.

First quarter Adjusted EBITDA was $33.3 million, representing a $1.0
million or 3.1% increase from $32.3 million for the same period of 2014.

Conference Call Dial-in Information

Agiliti will hold its quarterly conference call to discuss 2015 first
quarter results on Thursday, May 14, 2015 at 9:00 a.m. Eastern Time
(8:00 a.m. Central Time).

To participate, call (855) 539-7565 and advise the operator you would
like to participate in the Agiliti First Quarter 2015 Earnings Conference
Call. A recording of this call will be available from 11:00 a.m. Eastern
Time on May 14, 2015 through June 14, 2015 by calling (855) 859-2056;
enter conference ID 10555850.

Agiliti will also use a slide presentation to facilitate the conference call
discussion. A copy of the presentation may be obtained via the company’s
website at www.agilitihealth.com
in the “Who We Are” section. From this section, select “Financials” then

Adjusted EBITDA Reconciliation

Adjusted EBITDA is defined by Agiliti as Earnings Before Interest, Taxes,
Depreciation and Amortization (“EBITDA”) before management and board
fees, stock option expense, ASC 805 impact, loss on extinguishment of
debt and transaction and related costs, which may not be calculated
consistently among other companies applying similar reporting measures.
EBITDA and Adjusted EBITDA are not intended to represent an alternative
to operating income or cash flows from operating, financing or investing
activities (as determined in accordance with generally accepted
accounting principles (“GAAP”)) as a measure of performance, and are not
representative of funds available for discretionary use due to UHS’
financing obligations. EBITDA is included because it is a widely
accepted financial indicator used by certain investors and financial
analysts to assess and compare companies and is an integral part of UHS’
debt covenant calculations. Adjusted EBITDA is included because UHS’
financial guidance and certain compensation plans are based upon this
measure. Management believes that Adjusted EBITDA provides an important
perspective on the company’s ability to service its long-term
obligations, the company’s ability to fund continuing growth, and the
company’s ability to continue as a going concern. A reconciliation of
consolidated net income (loss) to EBITDA and Adjusted EBITDA is included

(In millions) 1st Quarter LTM





Net loss attributable to UHS $ (7.1 ) $ (9.7 ) $ (63.9 )
Interest expense 13.3 13.4 53.2
Provision (benefit) for income taxes 0.2 0.2 (13.1 )
Depreciation and amortization   24.4       25.8     98.7  
EBITDA 30.8 29.7 74.9
Intangible asset impairment charge 34.9
Management, board & strategic fees 2.1 0.9 6.8
Restructuring, acquisition and integration expenses 1.3 1.8
Stock option expense   0.4       0.4     2.3  
Adjusted EBITDA $ 33.3     $ 32.3   $ 120.7  

About Agiliti , Inc.

Agiliti , Inc. is a leading nationwide provider of
health care technology management and service solutions to the health
care industry. Agiliti owns or manages over 700,000 units of medical
equipment for over 7,000 national, regional and local acute care
hospitals and alternate site providers in all 50 states. For more than
75 years, Agiliti has delivered management and service solutions that help
clients reduce costs, increase operating efficiencies, improve caregiver
satisfaction and support optimal patient outcomes.

Agiliti , Inc.
6625 West 78th Street,
Suite 300
Minneapolis, MN 55439

Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995:
Agiliti , Inc., believes statements
in this presentation looking forward in time involve risks and
uncertainties. The following factors, among others, could adversely
affect our business, operations and financial condition causing our
actual results to differ materially from those expressed in any
forward-looking statements: our history of net losses and substantial
interest expense; our need for substantial cash to operate and expand
our business as planned; our substantial outstanding debt and debt
service obligations; restrictions imposed by the terms of our debt; a
decrease in the number of patients our customers are serving; our
ability to effect change in the manner in which healthcare providers
traditionally procure medical equipment; the absence of long-term
commitments with customers; our ability to renew contracts with group
purchasing organizations and integrated delivery networks; changes in
reimbursement rates and policies by third-party payors; the impact of
health care reform initiatives; the impact of significant regulation of
the health care industry and the need to comply with those regulations;
the effect of prolonged negative changes in domestic and global economic
conditions; difficulties or delays in our continued expansion into
certain of our businesses/geographic markets and developments of new
businesses/geographic markets; additional credit risks in increasing
business with home care providers and nursing homes, impacts of
equipment product recalls or obsolescence; increases in vendor costs
that cannot be passed through to our customers; and other Risk Factors
as detailed in our annual report on Form 10-K for the year ended
December 31, 2014, as well as our other filings with the Securities and
Exchange Commission.


Agiliti , Inc.
James Pekarek, 952-607-3054
Executive Vice President and Chief Financial Officer